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and TAZ operate as essential mechano-
sensors during tissue reprogramming.
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Tissue regeneration requires dynamic cellular adap-
tation to the wound environment. It is currently un-
clear how this is orchestrated at the cellular level
and how cell fate is affected by severe tissue dam-
age. Here we dissect cell fate transitions during
colonic regeneration in a mouse dextran sulfate so-
dium (DSS) colitis model, and we demonstrate that
the epithelium is transiently reprogrammed into a
primitive state. This is characterized by de novo
expression of fetal markers as well as suppression
of markers for adult stem and differentiated cells.
The fate change is orchestrated by remodeling
the extracellular matrix (ECM), increased FAK/Src
signaling, and ultimately YAP/TAZ activation. In a
defined cell culture system recapitulating the extra-
cellular matrix remodeling observed in vivo, we
show that a collagen 3D matrix supplemented with
Wnt ligands is sufficient to sustain endogenous
YAP/TAZ and induce conversion of cell fate. This
provides a simple model for tissue regeneration,
implicating cellular reprogramming as an essential
element.
INTRODUCTION
Intestinal epithelial stem cells ensure fast tissue replenishment.
These adult stem cells reside at the bottom of crypts and express
markers such as Lgr5, Olfm4, and Lrig1 (Barker et al., 2012).
Upon tissue damage, cells that are distinct from adult intestinal
stem cells contribute to wound repair, replenishment of lostCell Stem Cell 22, 35–49,
This is an open access article under the CC BY-Nstem cells, and restoration of tissue architecture (Blanpain and
Fuchs, 2014). Yet, the cellular responses underlying this remark-
able plasticity remain unclear.
Patients with inflammatory bowel disease, such as ulcerative
colitis (UC) and Crohn’s disease, have impaired intestinal barrier
function, and they experience recurrent severe inflammation.
Current treatment strategies aim to reduce the intestinal inflam-
mation burden in general, with only a limited focus on targeting
the epithelium to promote tissue regeneration. Tissue regenera-
tion is a complex process associated with pronounced changes
to the environment at both the cellular and biophysical levels
(Stappenbeck and Miyoshi, 2009). Sensing these environmental
changes and spatial information is, however, essential during tis-
sue regeneration. Two highly related transcriptional activators,
YAP and TAZ, have recently emerged as primary sensors of
the cellular microenvironment, integrating cell polarity and me-
chanical cues with growth factor signaling and inflammation
(Piccolo et al., 2014). In vitro, activation of YAP/TAZ has recently
been shown to dedifferentiate committed cells back to a progen-
itor and stem cell state (Panciera et al., 2016). YAP/TAZ-medi-
ated signaling appears dispensable during steady-state homeo-
stasis in the intestinal epithelium (Azzolin et al., 2014; Barry et al.,
2013; Cai et al., 2010). Evidence does, however, suggest an
important role of YAP during intestinal regeneration (Cai et al.,
2010). Yet, it remains largely unknown how YAP/TAZ signaling
is controlled during repair andwhich cellular processes are regu-
lated by YAP/TAZ during tissue remodeling.
Here we examine wound repair in the colonic epithelium and
identify markers for the repairing epithelium (RE). Characteriza-
tion of the repairing epithelium demonstrates a strong and
necessary response by the transcriptional regulators YAP/TAZ
driven by environmental changes. We provide evidence that
this can be recapitulated in vitro using defined cell culture condi-
tions in a YAP/TAZ-dependent manner. Moreover, the changes
associated with the repairing epithelium strongly suggest thatJanuary 4, 2018 ª 2017 The Authors. Published by Elsevier Inc. 35
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Repairing Intestinal Epithelium Has a Cellular and Molecular Profile Distinct from the Normal Epithelium
(A) Macroscopic images of the distal part of the colon in an untreated mouse (left) and a mouse 2 weeks post-administration of DSS (right). The demarcated area
indicates regions undergoing active re-epithelialization. Scale bar, 2 mm.
(B) H&E staining of homeostatic tissue and tissue in the repair phase at 2 weeks following DSS administration. Scale bar, 100 mm.
(C) The mucosal/submucosal thickness at homeostasis and repair phase (2 weeks). Shown are mean distances ± SEM (n = 4 animals; p = 0.007 based on two-
sided Student’s t test).
(D) Sca1 (green) expression in colonic epithelium in homeostatic and repair phase. Sections are counterstained with DAPI (blue). The demarcated line indicates
the epithelial structure. Scale bar, 100 mm.
(legend continued on next page)
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the tissue undergoes injury-assisted transition into a primitive
state with fetal-like properties. Importantly, the changes associ-
ated with the wound-induced reprogramming are reversible
both in vivo and in vitro, allowing the tissue to regain its normal
cellular architecture and adult-specific gene expression, when
regeneration is complete. We believe that understanding the
process of tissue repair and how this is orchestrated at the
cellular and molecular levels will provide better solutions for
enhancing regeneration.
RESULTS
The Repairing Epithelium Represents a Distinct
Transcriptional State
To investigate the mechanisms controlling tissue regeneration
following severe injury, we took advantage of the dextran sulfate
sodium (DSS) colitis model. Mice exposed to DSS for 5 days
developed epithelial ulceration in the colon (Figures 1A, 1B,
and S1A). Ulceration of the distal part of the colon was evident
approximately 1 week after DSS administration (Figure S1A).
This was followed by the formation of swelling islets (Figure 1A),
which were covered by a thickened hyperplastic repairing
epithelium (Figures 1B and 1C). At 1 month after the administra-
tion of DSS, tissue homeostasis was restored (Figure S1A).
Members of the LY6 superfamily of cell surface proteins are
upregulated during colitis (Flanagan et al., 2008). Moreover,
the LY6 member Stem Cell Antigen-1 (Sca1/Ly6a) has been
used extensively in the hematopoietic field to enrich for murine
hematopoietic stem cells (Morrison et al., 1995). We thus asked
whether Sca1 could represent a marker for the repairing epithe-
lium. Immunofluorescence time course analysis showed a dy-
namic regulation of Sca1, with initial elevated levels in the stroma
and subsequently very high levels specifically associated with
the swelling areas of the repairing epithelium (Figures 1D–1G
and S1B). This pattern was mirrored by the secreted bactericidal
C-type lectin Reg3b (Figure S1A). Further characterization of
the repairing epithelium demonstrated an elevated number of
proliferative cells (Ki67 positive) and fewer Muc2-expressing
secretory cells than in homeostatic tissue (Figures S1C and
S1D). Thus, the repairing epithelium expresses markers that
distinguish it from the homeostatic epithelium, indicating that
these cells have distinct properties.
To gain more insights into the molecular traits of the repairing
epithelium, we performed expression profiling on epithelial
cells purified from homeostatic tissue (EpCAMposSca1neg
CD45negCD31neg) and the repairing epithelium (EpCAMpos(E) Flow cytometric analysis of cells from the colonic epithelium during homeosta
representative plots for Sca1-PECy5 in live CD45veCD31veEpcam+ve cell popu
(F) Quantification of the percentages of Sca1high cells in homeostasis and repair p
Student’s t test).
(G) qRT-PCR analyses in Epcam+Sca1high cells sorted via FACS from the repa
average levels ± SEM (n = 3; Ly6a, p = 1.3 3 104; Reg3b, p = 9.7 3 103; Reg3
(H) Heatmap analysis of differentially expressed probe sets (fold change > 2.0;
homeostatic tissue and Sca1high cells from the repairing epithelium.
(I) Detection of Lrig1 (green) in homeostasis, early and late repair phase counters
(J) GSEA of repairing and homeostatic epithelium using Lgr5 intestinal stem cell
(K) Organoid formation for Epcam+ cells isolated from normal homeostasis, as w
sentative images of formed organoids. Bars represent average number of organ
See also Figure S1 and Table S1.Sca1highCD45negCD31neg). As expected, a number of genes
were differentially expressed between these purified epithelial
cell populations (424 probe sets up and 585 probe sets down;
fold change > 2; false discovery rate [FDR] < 0.05), reinforcing
the notion that the repairing epithelium represents a cellular
state profoundly different from the normal homeostatic epithe-
lium (Figure 1H). Gene ontology (GO) analyses for molecular
pathways illustrated that the Sca1high cells were specifically en-
riched in signaling cascades associated with chemokines and
inflammation, whereas metabolic pathways were repressed
(Figures S1E and S1F; Tables S1 and S2). Importantly, a number
of markers specifically associated with the adult stem cell state
were specifically repressed in the Sca1high state. This was
evident at the protein level, where expression of the stem cell
marker Lrig1 was reduced during the early phases of tissue
repair (Figure 1I; Wong et al., 2012), as well as at the RNA level,
where there was a general suppression of the gene signature
associated with Lgr5-expressing intestinal stem cells (Figure 1J;
Mun˜oz et al., 2012). Similarly, Sca1high cells were distinct from
Sca1low cells following experimental colitis (Figure S1E). Despite
the suppression of intestinal stem cell markers, Sca1high cells re-
tained in vitro stem cell potential (Figure 1K). This demonstrates
that the intestinal epithelium, as it progresses into the repair
phase, undergoes extensive changes, including the suppression
of normal markers of adult stem cell, without affecting stem cell
potential.
The Reprogrammed Repairing Epithelium Expresses
Primitive Fetal-Associated Markers
An assessment of the GO terms for biological processes associ-
ated with the repair phase revealed enrichment for transcrip-
tional processes linked with morphogenesis and development
(Figure S1F). We have previously demonstrated that the intesti-
nal epithelium has distinct fetal and adult stem cells that
can be propagated in vitro (Fordham et al., 2013). Expression
analysis of cultures derived from the fetal and adult epithelium
revealed that Sca1 was transcriptionally upregulated by fetal
organoids along with a number of other Ly6 family members
(Figures 2A and 2B). In vivo these observations were paralleled
by the robust expression of Sca1 in the fetal colonic epithelium
(Figure 2C), whereas it was absent in the adult homeostatic
colonic epithelium (Figure 1D). All in all, this demonstrates that
Sca1 is expressed by more primitive epithelia both in vitro and
in vivo. Transcriptionally, gene set enrichment analysis (GSEA)
of fetal signature genes (>2-fold; FDR < 0.05; fetal versus adult
organoids) revealed a significant enrichment in the repairingsis and in repair phase (2 weeks post-administration of DSS). Diagrams show
lation.
hase. Diagram shows average ± SEM (n = 3; p = 43 105 based on two-sided
iring epithelium and in homeostatic epithelial cells (Epcam+). Bars represent
g, p = 8.5 3 103 based on two-sided Student’s t test).
FDR < 0.05), comparing the expression profile of epithelial cells isolated from
tained for E-cadherin (red) with DAPI (blue). Scale bar, 50 mm.
gene signature.
ell as Epcam+ Sca1low and Sca1high cells during tissue repair showing repre-
oids formed ± SEM (n = 3 animals).
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Figure 2. The Repairing Epithelium Adopts a Fetal-like Expression Profile
(A) Sca1 (green) expression in organoids from adult animals (Adult) and in fetal organoids (Fetal) derived from the proximal small intestine. Insets show the
enlarged view of the indicated region. Images are counterstained with DAPI (blue). Scale bar, 50 mm.
(B) Heatmap of differentially expressed probe sets showing genes upregulated more than 2-fold comparing adult organoids (green) and fetal organoids (red)
(n = 3; fold change > 2; FDR < 0.05). Multiple members of Ly6 and Annexin gene families are upregulated in the fetal cells.
(C) Sca1 (green) expression in fetal colon at embryonic day (E)16.5 counterstained with EpCAM (red) and DAPI (blue). Scale bars, 50 mm.
(D) GSEA showing enrichment of the fetal intestinal gene signature in the repairing epithelium.
(E) Anxa1 (green) expression in adult organoids (Adult) and fetal organoids (Fetal) derived from the proximal small intestine. Images are counterstained with
E-cadherin (red) and DAPI (blue). Scale bar, 100 mm.
(F) Anxa1 (green) expression in fetal colon at E16.5, colon in homeostasis and in the repair phase. Images are counterstained with E-cadherin (red) and DAPI
(blue). Scale bars, 50 mm for fetal colon and 100 mm for adult colon.
(G) ANXA1 (green) in colonic biopsy from non-inflamed and inflamed regions obtained from a patient with ulcerative colitis. Images are counterstained with
E-cadherin (red) and DAPI (blue). Scale bar, 100 mm.
(H and I) GSEAs showing enrichment of the transcriptional signatures for the mouse repairing epithelium (H, mRepair) andmouse fetal state (I, mFetal) in samples
isolated from patients with active colitis (hColitis) compared to control individuals (hNormal).
See also Figure S2 and Table S2.
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Figure 3. The Repairing Epithelium Displays Features of Active Mechano-Transduction
(A) Differentially expressed probes ranked in heatmap comparing tissue homeostasis and repair phase (n = 3; 2-fold regulated; FDR < 0.05). Selected genes
associated with lineage differentiation and extracellular matrix interactions are indicated.
(legend continued on next page)
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epithelium when compared to the normal adult epithelium,
strongly suggesting that the repairing epithelium represents an
earlier developmental stage (Figure 2D). To further substantiate
this observation, we assessed the expression of Annexin A1
(Anxa1), which was elevated in fetal organoids (Figures 2B and
2E), and Tacstd2/Trop2, which marks fetal progenitors (Mustata
et al., 2013). Evidently, Anxa1 expression was upregulated both
in the fetal and repairing epithelium (Figures 2F and S2A), and
Tacstd2/Trop2 was also elevated during the repair phase and
by fetal organoids (Figures S2A–S2C). These observations are
consistent with the notion that, upon colonic injury, regeneration
involves transcriptional reprogramming of epithelial cells to a
more primitive state.
We next evaluated human clinical material to address whether
the observed reprogramming occurs following severe inflamma-
tion. As there is no human homolog of Sca1, we analyzed ANXA1
in intestinal specimens obtained by colonoscopy from non-in-
flamed areas and areas with active disease in the same patient
with ulcerative colitis. Similar to our observations in mouse,
ANXA1 was highly expressed in the areas of flaring disease,
where the epithelium was in a state of regeneration as compared
to the non-inflamed part (Figure 2G). Analyses of publicly avail-
able gene expression datasets from colonic tissue from patients
with active ulcerative colitis and normal colon tissues (Van der
Goten et al., 2014) further substantiated this finding, as genes
upregulated by the repairing epithelium (>2-fold; FDR < 0.05;
mRepair) and the fetal gene signatures (mFetal; Figures 2H and
2I; Table S3) were enriched in tissue from ulcerative colitis pa-
tients. We conclude that extensive transcriptional rewiring oc-
curs upon regeneration in human ulcerative colitis and following
DSS-induced colitis in mouse models.
The Repairing Epithelium Displays Elevated Integrin/
FAK Signaling and YAP Activation
To investigate the molecular mechanism for the observed cellular
reprogramming, we turned to the transcriptional profiles associ-
ated with the repairing epithelium, where we observed a pro-
found repression of genes associated with secretory lineage. In
contrast, several extracellular matrix components, including
collagen type I, were highly elevated in the repairing epithelium
(Figures 3A and S3A). This was also evident from GO analyses,
where integrin signaling was among the most enriched pathways
in the Sca1high population (Figure S1F). These gene responses
correlated well with the pronounced changes in the wound bed,
as detected by second harmonic generation microscopy, where(B) Second harmonic generation (Collagen; green) overlapped with bright-field m
lines indicate crypts and muscularis mucosa. Arrows indicate collagen fibers enc
(C) Detection of b1 integrin, FAK, pSrc, and Phalloidin (green) during the repair pha
(blue). Scale bars, 100 mm for b1 integrin, FAK, and pSrc and 50 mm for Phalloidi
(D) Detection of YAP (green) during the repair phase and homeostasis. Inset sho
counterstained with E-cadherin (red) and DAPI (blue). Scale bars, 100 mm.
(E) GSEA showing enrichment of a YAP gene signature in repairing relative to no
(F) Weight curves for animals treated with DSS and subsequently with either vehic
average weight relative to the starting point ± SEM (n = 5 for all groups). Signifi
multiple comparisons (Srcinhib versus Ctrl day 9, p = 0.02; day 10, p = 0.004; day 11
p = 2 3 104; day 11, p = 104; and day 12, p < 104).
(G) Detection of YAP (green) during the repair phase (day 12) in vehicle and S
E-cadherin (red) and DAPI (blue). Scale bars, 50 mm.
See also Figure S3.
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(Figure 3B). Changes in the signaling between the extracellular
matrix (ECM) and epithelial cells are sensed by transmembrane
collagen receptors of the integrin family, activating focal adhesion
kinase (FAK) and Src to control actin cytoskeleton rearrangement
(Kim andGumbiner, 2015). In linewith the exposure to thewound-
associated matrix, the repairing epithelium displayed elevated
levels of the collagen receptor b1 integrin subunit and FAK at
the basolateral cell surface, as well as enhanced levels of
phosphorylated Src (pSrc) and loss of polarized F-actin filaments
(Figures 3C and S3B). This reveals that the repairing epithelium is
influenced by the altered environmental stimuli and mechanical
properties of the dense collagenmatrix present in thewound bed.
YAP and TAZ are overarching mechano-transducers and key
transcriptional regulators of cell fates (Dupont et al., 2011). In
line with the altered accumulation and activation of components
of the focal adhesion pathway, the number of cells with nuclear
accumulation of YAP was highly elevated during the repair
phase, when compared to the small subsets of positive cells in
the normal epithelium (Figures 3D and S3C). Moreover, GSEA
with a reported YAP/TAZ activity gene signature showed a highly
significant enrichment in the repairing epithelium (Figure 3E;
Gregorieff et al., 2015). The combination of YAP nuclear retention
and YAP/TAZ transcriptional activation provides strong evi-
dence that YAP/TAZ-mediated signaling is activated during tis-
sue regeneration.
To test whether signaling downstream of integrins is important
for tissue repair and the localization of the mechano-sensor
YAP, animals were treated with FAK and Src inhibitors during
the transition from ulceration to the repair phase. We found
that the activation of both pathway components was important
for tissue repair, as mice treated with the inhibitors showed de-
layed repair following injury in line with previous reports (Cordero
et al., 2014; Owen et al., 2011; Figure 3F). Moreover, large ulcer-
ative regions remained in animals treated with both inhibitors
(Figures S3D–S3G), and the remaining epithelium had very few
cells with nuclear YAP and signs of active tissue remodeling
(Figures 3G and S3H). This demonstrates that cell mechanics
via the FAK pathway is important for colonic repair and the
establishment of the highly proliferative repairing epithelium.
Rebuilding the Repairing Epithelium In Vitro Based on
Defined Components
Based on the pronounced remodeling of the extracellular
matrix during the repair phase, we hypothesized that theseicroscopy in tissue sections from homeostasis and repair phase. Demarcated
apsulating de novo-formed crypts. Scale bar, 50 mm.
se and homeostasis. Images are counterstained with E-cadherin (red) and DAPI
n.
ws enlarged view of a single colonic crypt during homeostasis. Sections were
rmal colonic epithelium.
le or FAK and Src inhibitors during tissue repair. Individual points represent the
cance was assessed using a two-way ANOVA with Bonferroni correction for
, p = 0.03; and day 12, p = 0.01; FAKinhib versus Ctrl day 9, p = 43 104; day 10,
rcinhibitor- and FAKinhibitor-treated animals. Sections were counterstained with
Figure 4. Rebuilding the Repairing Epithelium In Vitro Based on Defined Components
(A) Murine small intestinal epithelial cells cultured in the presence of EGF, Noggin, and R-spondin1 (ENR) or with the addition of Wnt3a (+Wnt3a) in either Matrigel
or collagen type I. Scale bars, 100 mm.
(B) Heatmap of differentially expressed probe sets between culture conditions using MG/ENR+Wnt3a (ENRW, green) and COL/ENRW (red) (n = 6; fold change >
1.5; FDR < 0.1). Examples of differentially expressed genes are indicated.
(C) Detection of F-actin with Phalloidin (gray) counterstainedwith DAPI (blue) and YAP (green) counterstainedwith E-cadherin (red) and DAPI (blue) inMatrigel and
collagen type I cultures from the small intestine. Insets show enlarged view of the indicated regions. Scale bars, 50 mm in the top panels and 100 mm in the bottom
panels.
(D) Heatmap of Z score-transformed relative expression levels as determined by qPCR for selected YAP/TAZ target genes and markers of the fetal and adult
states in cultures of small intestinal epithelial cells grown in either Matrigel (MG) or collagen type I (Col) in the presence of EGF/Noggin/Rspondin (ENR) with or
without Wnt3a (W).
(legend continued on next page)
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environmental changes have inductive properties. To test this,
we took advantage of a 3D culture system for the adult small in-
testine (Sato et al., 2009). Unlike primary cells from the colon,
small intestinal epithelial cells can be cultured as organoids un-
der minimal conditions in the presence of epidermal growth fac-
tor (EGF), Noggin, and R-spondin1 (Sato et al., 2009, 2011).
These organoids are typically cultured in Matrigel, consisting pri-
marily of laminins and collagen IV.
Collagen type I was prominently upregulated during the repair
phase (Figures 3B and S3A), but gels consisting of pure collagen
type I did not support cultures of intestinal epithelial cells in
medium supplemented with EGF, Noggin, and R-spondin1,
whereas a combination of collagen type I and Matrigel did
(Figures 4A and S4A). This suggests that collagen type I itself
was not prohibiting expansion of small intestinal epithelial orga-
noids and that additional factors should be incorporated to
phenocopy the inductive microenvironment for the repairing
epithelium. Recent evidence with artificially designed matrices
indicates that conditions that sustain YAPactivation canmaintain
primary epithelial cells in vitro (Gjorevski et al., 2016). Augmenta-
tion of canonical Wnt signaling has been connected to efficient
tissue repair, and canonical Wnt factors cooperate with cell me-
chanics to sustain YAP/TAZ activation in normal and cancer cells
(Azzolin et al., 2012; Panciera et al., 2016). This prompted us to
investigate whether the combined stimulation of the canonical
Wnt pathway together with collagen type I could install an repair-
ing epithelium-like phenotype in vitro. Strikingly, we found that
this combination supported the in vitro expansion of epithelial
cells as spheroids for multiple passages in a transcriptionally
distinct state (Figures 4A, 4B, andS4A). Itwas recently suggested
that prostaglandin E2 (PGE2) acts via the activation of YAP in vivo
(Kim et al., 2017); however, PGE2 cannot replace Wnt3a nor is
the activity of the critical enzymes responsible for PGE2 pro-
duction, Cox1 and Cox2, required for maintenance in collagen
(Figure S4A). Importantly, the addition of Wnt3a to standard
Matrigel cultures also promoted a spherical phenotype, but
with occasional budding domains (Figures 4A and S4A).
Under collagen conditions, analogously to the in vivo colitis
samples, the apical F-actin belt was lost and YAP was retained
in the nuclei (Figures 4C and S4B). At the molecular level, stem
cell (Lgr5, Olfm4, and Ascl2) and differentiation markers (Lyz1,
Muc2, ChgA, Def6a, Lct, and Atoh1) were repressed, whereas
the YAP/TAZ target genes (Ctgf, Ankrd1, Ereg, and Cyr61) as
well as reprogramming marker Ly6a were induced (Figure 4D).
Moreover, the epithelium started to express both Sca1 and
Anxa1 (Figure 4E). Sca1 expression was retained after spheroid
passaging, indicating that the Wnt/collagen condition installed a
stable cellular state that recapitulated the cellular response dur-
ing tissue repair. Transcriptional analysis confirmed that cells
cultured under these conditions in vitro were remarkably similar
to the gene profiles of the repairing epithelium in vivo (Figure 4F),
including a prominent activation of YAP and fetal gene signa-(E) Detection of Sca1 (green, left) and Anxa1 (green, right) in collagen type I cultu
Images are counterstained with DAPI (blue) and image for Anxa1 is additionally c
(F) GSEA showing enrichment of the collagen culture gene signature in the repai
(G) GSEA showing enrichment of YAP and fetal gene signatures in ENRW-Collag
(H) Mouse and human colonic organoids propagated in collagen type I. For human
See also Figure S4.
42 Cell Stem Cell 22, 35–49, January 4, 2018tures (Figure 4G) and suppression of the Lgr5 stem cell signature
(Figure S4C). Moreover, the conditions could be applied to both
mouse and human colonic epithelial cells (Figure 4H), where
overt transcriptional overlaps could be detected between adult
colonic organoids cultured in collagen type I and fetal colonic or-
ganoids (Figure S4D). Importantly, inhibitors affecting signaling
downstream of integrins via Rho kinase (C3 toxin; Mevastatin)
and actin polymerization (Cytochalasin D) all significantly
reduced growth in collagen type I (Figure S4E; Dupont et al.,
2011; Sorrentino et al., 2014). Similarly, the FAK and Src inhibi-
tors that affected tissue repair in vivo (Figure 3F) reduced growth
in collagen type I (Figure S4E). This demonstrates the impor-
tance of matrix-mediated integrin signaling, and it suggests
that mechano-transduction via YAP/TAZ is important for growth
in collagen type I.
YAP and TAZ Promote Cellular Reprogramming
The above experiments suggest that YAP/TAZ act downstream
of cell mechanics and Wnt signaling in cells of the repairing
epithelium. Wnt signaling has previously been demonstrated to
stimulate YAP/TAZ activation via the inhibition of Adenomatous
Polyposis Coli (Apc)-mediated degradation (Azzolin et al.,
2012, 2014). As expected, in collagen cultures Wnt3a could be
substituted by the loss of Apc (Figures 5A and 5B). Moreover,
ApcKO organoid growth could be blocked by treatment with
the YAP/TAZ inhibitor verteporfin (Figure 5C). This demonstrates
that Wnt via inhibition of the Apc complex supports growth in
collagen type I via YAP/TAZ activation. This is similar to the re-
ported requirement for YAP/TAZ during tumor formation upon
the loss of Apc (Azzolin et al., 2014). Notably, blunting YAP/
TAZ mechano-transduction by the inhibition of Rho signaling
also opposed the growth of ApcKO organoids, a result consistent
with the requirement of cell mechanics for YAP/TAZ activation in
the repairing epithelium in vivo (Figure 5C). Importantly, even in
the ApcKO model, cell mechanics were still causal for sustaining
YAP/TAZ target genes (Cyr61 and Ctgf) and the associated
appearance of markers associated with the fetal epithelium
(Tacstd2 and Ly6a). This suggests that in our ex vivo-culturing
conditions, activation of Wnt signaling and cell mechanics are
additive signals for YAP/TAZ activation, but that cell mechanics
remain essential for Wnt-induced YAP/TAZ activity.
To directly assess the requirements for YAP/TAZ in the context
of collagen-induced cellular reprogramming, we took advantage
of both loss- and gain-of-function mutants. Using an inducible
conditional double-knockout (cDKO) model for YAP/TAZ (Azzo-
lin et al., 2014), it was evident that YAP/TAZ are required for
growth in collagen type Imatrices (Figure S5A). Intriguingly, over-
expression of YAP in epithelial cells derived from the R26-rtTA;
tetO-YAPS127A mouse model could compensate for the pres-
ence of Wnt in the culture medium (Figures 5E and 5F). More-
over, induction of exogenous YAPS127A expression in collagen
rescued the detrimental effects of FAK and Src inhibition onres from the small intestine. Inset shows enlarged view of the region indicated.
ounterstained with E-cadherin (red). Scale bars, 50 mm.
ring epithelium.
en relative to ENRW-Matrigel cultures.
colonic crypts, Prostaglandin E2 (PGE2) is supplemented. Scale bar, 100 mm.
Figure 5. YAP/TAZ Transcriptional Activation Is Required for Cellular Reprogramming
(A) Normal organoids (WT) and Apc-knockout (ApcKO) spheres derived from the small intestine cultured in collagen type I with the indicated cytokine cocktail.
Time point of analysis is indicated in the left bar. Scale bar, 100 mm.
(legend continued on next page)
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growth (Figure 5F), demonstrating that YAP/TAZ activation lies
downstream of the integrin-mediated mechano-transduction
pathway. Importantly, the establishment of the repairing epithe-
lium-like status in vitro via culturing in collagen type I, with either
Wnt3a supplemented or by overexpression of YAP, led to a
similar upregulation of markers of the fetal epithelium as well
as a pronounced downregulation of markers associated with
adult stem cells and differentiated lineages (Figure 5G). Collec-
tively, gain- and loss-of-function lines of evidence concur at
demonstrating that YAP/TAZ-mediated activation is required
and sufficient for establishing the repairing epithelium-like state
in vitro.
YAP and TAZ Are Required during Tissue Regeneration
To address the role of both YAP and TAZ in colonic tissue
repair, we induced conditional loss of the two factors in the adult
intestinal epithelium using the Villin-CreERT2 cDKO by adminis-
tration of tamoxifen 2 weeks prior to the induction of colitis. As
reported previously, loss of YAP/TAZ does not affect normal tis-
sue homeostasis (Figures S5B and S5C; Azzolin et al., 2014).
Upon the administration of DSS, at concentrations with minor ef-
fects on controls animals, cDKO animals rapidly lost weight, and
ulcerated lesions spread throughout the colon similarly to the an-
imals treated with either FAK or Src inhibitors (Figures 5H–5K).
Importantly, the epithelium remaining in the YAP/TAZ cDKO
could be divided into what appeared to be normal regenerating
epithelium positive for YAP, demonstrating that these cells had
escaped recombination, and thin-walled cysts found exclusively
in the cDKO animals, where YAP and Sca1 were absent (Figures
5L, 5M, and S5E). This demonstrates that YAP and TAZ are
required during the process of repair following DSS-mediated
injury and tightly linkedwith establishing the Sca1-expressing re-
pairing epithelium.
In experiments, where organoids grown in Matrigel are trans-
planted to the colon of animals by infusion (Yui et al., 2012), we
also noticed that patches of engrafted cells displayed not only(B) Quantification of seeding efficiency for WT and ApcKO organoids in Noggin
mean ± SEM (n = 3; EN versus +RW for WT, p = 4.8 3 106 based on two-sided
(C) Quantification of seeding efficiency for ApcKO organoids in collagen with me
1.8 3 105 based on two-sided Student’s t test).
(D) Heatmap of Z score-transformed relative expression levels as determined by
states in ApcKO organoid cultures in EGF/Noggin in either Matrigel (MG) or collag
(E) Spheroids derived from the small intestine of Rosa26-rtTA;tetO-YAP-S127
cocktail ± Doxycycline. Time point of analysis is indicated in the left bar. Scale b
(F) Quantification of seeding efficiency for organoids from rtTA/tetOYAP cultured
measured in the presence of either Src or FAK inhibitors. Bars represent mean ±
(G) Heatmap of Z score-transformed relative expression levels as determined by
states in rtTA/tetOYAP organoids cultured inmatrigel (MG) or collagen type I supp
expression.
(H) Weight curve for Yapfl/fl;Tazfl/fl (Ctrl) and Vil-CreERT2;Yapfl/fl;Tazfl/fl conditional d
presented (Ctrl n = 6; cDKO n = 4). The observed differences are significant from
multiple comparisons (day 8, p = 6 3 104; day 9 onward, p < 104).
(I) Representative H&E staining of Swiss roll of DSS-treated colon from Ctrl and c
(J) Quantification of the length of the denuded area in Ctrl and cDKO colons. Data
Whitney exact two-sided test).
(K) Boxed areas from (I) shown in higher magnification. Scale bar, 100 mm.
(L) Detection of YAP (green) and Sca1 (red) during the repair phase in tissue from cD
epithelial cysts without YAP and Sca1 expression. Scale bar, 100 mm.
(M) Quantification of YAP/Sca1 status in remodeling crypts and epithelial cysts o
p < 104 based on two-way ANOVA).
See also Figure S5.
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of Sca1 (Figures 6A and 6B). This illustrates that the cells trans-
planted into the epithelium, including those cultured in traditional
Matrigel-based organoid medium, recapitulated the phenotyp-
ical changes associated with tissue regeneration. Next, we
tested the requirement of YAP/TAZ in intestinal organoid engraft-
ment into a damaged epithelium, a proxy of regenerative medi-
cine application for ulcerative colitis. Crypts isolated from
cDKO animals were labeled to express GFP, and control cells
expressing tdTomato were expanded in vitro in Matrigel condi-
tions. Organoid fragments from both control and cDKO organo-
ids were infused into the colonic lumen following DSS-induced
colitis, and YAP/TAZ deletion was induced by two applications
of 4-hydroxy tamoxifen (4OHT; Figure 6C). Initially, the areas
covered by GFP-expressing cDKO and tdTomato-expressing
wild-type cells were equivalent (Figures 6D, 6E, and S6A). How-
ever, 3 days following the administration of 4OHT, it was evident
that very few areas covered by cDKO cells remained, when
compared to control cells (Figures 6D, 6E, and S6A). In sections,
the control cells (red) formed large crypts, whereas the remaining
cDKO (green) cells were found as small clusters of cells (Fig-
ure 6F, F’ and F’’). This demonstrates that YAP and TAZ act as
key effectors of the environmental signals that govern the main-
tenance of the repairing epithelium.
Injury-Induced Cellular Reprogramming Is Reversible
Regeneration is a reversible process orchestrated from residual
cells leading to the formation of a de novo-formed tissue. It fol-
lows that the tissue architecture, which normally provides the
framework and context for homeostatic cell behavior is tempo-
rarily lost. Thus, cell fate is dynamically regulated in vivo during
tissue repair.
To address whether cells can reversibly transit between a ho-
meostatic and repair-like state, we took advantage of the
collagen type I culture system. Intriguingly, epithelial cells that
were propagated in collagen type I converted efficiently intoand EGF (EN) with or without R-spondin and Wnt3a (RW). Bars represent
Student’s t test).
vastatin (Mev) and verteporfin (VP). Bars represent mean ± SEM (n = 3; p =
qPCR for selected YAP/TAZ target genes and markers of the fetal and adult
en type I (Col).
A (rtTA/tetOYAP), cultured in collagen type I under the indicated cytokine
ar, 100 mm.
with Wnt3a and doxycycline in collagen type I. Additionally, the efficiency is
SEM (n = 3).
qPCR for selected YAP/TAZ target genes and markers of the fetal and adult
lemented with either Wnt3a (no Dox) or Doxycycline (Dox) to induce YAP S127A
ouble knockout (cDKO) animals following DSS administration. Mean ± SEM is
day 8 and onward based on two-sided ANOVA with Bonferroni correction for
DKO animals at 13 days following the administration of DSS. Scale bar, 1 mm.
are presented as mean ± SEM (Ctrl n = 6; cDKO n = 4; p = 0.019 with a Mann-
KO animals at day 13 following DSS administration. Demarcated lines indicate
bserved in the cDKO tissue (n = 3 animals; 50–200 cells scored per condition;
Figure 6. Injury-Induced Cellular Reprogramming Is Reversible
(A and B) Serial sections of engrafted patches from Matrigel cultures analyzed for (A) tdTomato (red) and Sca1 (green) and (B) YAP (green) and E-cadherin (red)
1 day after transplantation (day 12). Scale bar, 100 mm.
(C) Diagram of the transplantation strategy using cells from the conditional YAP/TAZ cdKO cells and control animals. Indicated are the administration of DSS (day
0–5), time points for transplantation (days 8 and 11), administration of 4-hydroxy tamoxifen (days 12 and 13), as well as the final analysis (day 16).
(D) Whole-mount analysis of the colon for control (tdTomato+/red) and Villin CreER YAP/TAZ cDKO cells (eGFP+/green) before (day 12) and after (day 16)
tamoxifen administration. Arrows illustrate areas of GFP+ cells.
(E) Quantification of the ratio of the area covered by GFP- versus RFP-expressing cells before and after tamoxifen treatment. Each dot represents independent
animals, and data are presented as the mean ± SEM (p = 0.029 based on a Mann-Whitney exact one-sided test).
(legend continued on next page)
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adult-like organoids of substantially greater complexity, consist-
ing of domains enriched in prospective stem and differentiated
cells, when transferred to Matrigel (Figure 6G). Transcriptionally,
the levels of the reprogramming marker Sca1, the YAP/TAZ
target gene Ctgf, and stem cell (Olfm4) and lineage (Lyz1,
Muc2, and ChgA) markers were reversibly regulated by the ma-
trix (Figure 6H). This demonstrates the plasticity of cell fate and
the fact that cells are indeed capable of reversible transitioning
between different cellular states. Crucially, when transplanted
into the colonic injury model, small intestine-derived cells
cultured in collagen type I, similarly to cells cultured in Matrigel,
retained the capacity to contribute to tissue regeneration
(Figure 6I). The efficiency and sizes of engraftment were remark-
ably similar between Matrigel and collagen conditions (engraft-
ment efficiencies: collagen 60% and Matrigel 50%). Analysis of
the engrafted regions showed re-expression of appropriate
secretory lineage markers and retention of markers associated
with their original small intestinal identity (Figures S6B and
S6C). Taken together, this not only demonstrates the reversible
nature of cellular reprogramming of intestinal epithelial cells
(Figure 6J) but also outlines essentially clinical compliant culture
conditions relying on clinical grade collagen type I. This could
complement Matrigel-based culturing systems, which when it
comes to medical applications is undesirable, as the matrix is
purified from animals and chemically undefined.
DISCUSSION
In summary, we reveal that the colonic epithelium during tissue
repair is reprogrammed into a primitive state with fetal-like prop-
erties. This change of fate occurs downstream of signaling from
the extracellular matrix during tissue repair. This mechano-sen-
sory pathway entails activation of the focal adhesion pathway,
cytoskeletal re-arrangement, and YAP/TAZ activation. We
demonstrate that YAP and TAZ integrate mechanical, architec-
tural, as well as soluble signals during intestinal epithelial repair
to promote tissue regeneration. Reprograming into the highly
proliferative repairing epithelium by YAP/TAZ is a reversible pro-
cess that fuels regeneration. We propose that the ability to acti-
vate YAP/TAZ allows tissues to handle injuries by enabling cells
to rapidly suppress differentiation of adult fates via transitioning
into amore primitive fetal-like state (Figure 6G). This state is tran-
sient, persisting only until the return of the normal homeostatic
microenvironment. Our findings point to a physiological role for
YAP/TAZ in cellular reprogramming during tissue repair, and
they extend previous observations using the forced expression
of YAP (Panciera et al., 2016). This is potentially a broader
phenomenon, since regeneration in other tissues also has(F) Section of area with engrafted RFP- (red) and GFP- (green) expressing cel
bar, 100 mm.
(G) Small intestinal epithelial cells cultured for 3 passages (P3) in collagen type I w
the presence of ENR. Inset shows secretory cells in an organoid. Scale bar, 100
(H) Heatmap of Z score-transformed relative expression levels as determined by q
in ENR in MG (Matrigel), then transferred into collagen and cultured in the prese
(Matrigel replating).
(I) Engrafted patches (red) from tdTomato-expressing cells cultured for 3 passag
(J) Model depicting how environmental changes control cellular identity during ti
See also Figure S6.
46 Cell Stem Cell 22, 35–49, January 4, 2018been reported to involve some degree of reprogramming of resi-
dent cells (Fernandez Vallone et al., 2016; Yanger et al., 2013).
Future studies will be needed to elucidate the role of YAP/TAZ
in the transition into the primitive state observed during tissue
repair, and YAP/TAZ’s role in the fetal epithelium.
Studies of colonic regeneration illustrate that the process is
divided into discrete elements. First, a dormant wound-associ-
ated epithelium spreads over the wound in a Wnt5a-dependent
manner (Miyoshi et al., 2017). Second, we now show that the
epithelium enters a highly proliferative phase, where de novo
crypt formation ensures that the tissue can regain prior functional
features. In the absence of YAP/TAZ, a thin epithelium covers
parts of the wounded regions, illustrating that defects lie in the
establishment of the highly proliferative adaptive repairing
epithelium. The phenotypic importance of integrin-mediated
signaling has been implicated in the control of intestinal tissue
repair following severe injury (Cordero et al., 2014; Owen et al.,
2011; Taniguchi et al., 2015). Our data reveal that key signaling
events downstream of integrins via FAK and Src control the me-
chano-sensors YAP/TAZ following injury. Similarly, previous
studies have implicated YAP as an essential component in the
response to colonic repair (Cai et al., 2010; Taniguchi et al.,
2015). Our data support these observations, and they provide
insight into how the pathway is activated via tissue remodeling
and the consequences of YAP/TAZ activation. Moreover, we
reveal that YAP and TAZ are essential during tissue repair, spe-
cifically in the establishment of the highly proliferative repairing
epithelium, which governs regeneration.
One of the prominent components supporting cell behavior
in vivo is the connective tissue, which provides a framework for
appropriate organ functions. As with soluble growth factors,
the scaffold consisting of various extracellular matrix compo-
nents can be subjected to dynamic changes during tissue repair.
Our results underscore the fact that the matrix is not only an inert
scaffold but also an essential component that provides the
context for specific signaling networks. In the case of the intes-
tinal epithelium, changing the matrix into a collagen type I-en-
riched condition causes a completely reversible suppression of
cellular identities. This is important to consider from a cancer
perspective, where ulcerative colitis is a known risk factor for
the development of colorectal cancer (Beaugerie and Itzkowitz,
2015). It is tempting to speculate that patients with ulcerative co-
litis, exhibiting uncontrolled inflammation and fibrosis, are at risk
of developing cancer due to unchecked YAP/TAZ mechano-
transduction. Interestingly, cohort studies revealed that the
mutational spectrum in ulcerative colitis-associated colorectal
cancer is distinct from that of sporadic cancer, including a lower
prevalence of APC mutations (Robles et al., 2016; Yaeger et al.,ls. The engraftments are shown at higher magnification in F’ and F’’. Scale
ith ENRW grow as organoids, when replated in Matrigel (replating passage 3) in
mm.
PCR for selected various markers expressed by fetal and adult epithelia grown
nce of ENRW (Collagen), and lastly replated in Matrigel and cultured in ENR
es in either collagen type I or Matrigel. Scale bars, 2 mm.
ssue repair via YAP/TAZ signaling.
2016). This implies that environmental stimulation of the YAP/
TAZ pathway could bypass the requirements for loss of APC
function.
Transcriptional networks have been the main focus as the
framework that provides irreversible fate choices. The inductive
potential of such networks are evident by their ability to repro-
gram otherwise terminally differentiated cells into either a more
primitive state or a completely different cell lineage (Blanpain
and Fuchs, 2014). Interestingly, recent work has illustrated that
forced expression of the transcription factor YAP is capable of
yet a different form of cellular reprogramming, that is, to convert
differentiated cells from the mammary gland, pancreas, and
neuronal lineage into the respective lineage-restricted, tissue-
specific stem cell populations (Panciera et al., 2016). We specu-
late that the observed reprogramming into a fetal-like state upon
tissue damage could represent a physiological counterpart to
these in vitro observations, where tissue and germ layer identity
is still maintained.
The in vitro model system for studying the intestinal epithe-
lium using defined components in its repair phase or the transi-
tion between normal and repair is likely to have widespread
impact on the field. First, it is based on off-the-shelf-compo-
nents, which enable the in vitro expansion of clinical grade pri-
mary epithelial cells that would be suitable for clinical applica-
tions in patients with inflammatory bowel disease. Second,
the fact that the culture conditions are fully defined enables sys-
tematic studies aimed at addressing how signaling networks
operate in primary epithelial cells. Lastly, we highlight that the
described in vitromodel for tissue repair will improve our under-
standing of how tissue repair proceeds as well as the potential
establishment of in vitro disease models (Schweiger and Jen-
sen, 2016). Future studies should elucidate whether patients,
who experience bowel inflammation/ulcerations, will benefit
from therapies modulating either the YAP/TAZ levels directly
or indirectly, including changing the biophysical properties of
the wound bed.STAR+METHODS
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Rat anti Sca1 (177228) R&D systems Cat #: BAM1226, RRID:AB_2070040
Rabbit anti Anxa1 Invitrogen Cat #: PA5-27315, RRID:AB_2544791
Mouse anti E-cadherin (36/E-cadherin) BD Transduction Laboratory Cat #: 610181, RRID:AB_397580
Rat anti E-cadherin (ECCD-2) Thermo Fisher Scientific Cat #: 13-1900, RRID: AB_86571
Rat anti b1 integrin (MB1.2) Millipore Cat #: MAB1997, RRID: AB_2128202
Rabbit anti FAK Millipore Cat #: 06-543, RRID: AB_310162
Rabbit anti pSrc (Tyr416) Cell Signaling Technology Cat #: 2101, RRID: AB_331697
Rabbit anti YAP Cell Signaling Technology Cat #: 4912, RRID:AB_2218911
Rabbit anti Lysozyme (EC.3.2.1.17) Dako Cat #: A0099, RRID:AB_2341230
Rabbit anti Ki67 Abcam Cat #: ab15580, RRID: AB_443209
Rabbit anti MUC2 (H-300) Santa Cruz Cat #: sc-15334, RRID: AB_2146667
Rabbit anti Carbonic Anhydrase II (H-70) Santa Cruz Cat #: sc-25596, RRID: AB_2065996
Goat anti Lrig1 R&D systems Cat #: AF3688, RRID: AB_2138836
Rabbit anti EpCAM B.N.G. Giepmans Schnell et al., 2013
Rat anti Reg3b antibody R&D systems Cat #: MAB5110, RRID: AB_2178585
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Alexa Flour 488 Donkey anti Rat IgG (H+L) Thermo Fisher scientific Cat #: A-21208, RRID: AB_141709
Alexa Flour 555 Donkey anti Rat IgG (H+L) Abcam Ab-150154
Alexa Flour 488 Donkey anti Rabbit IgG (H+L) Thermo Fisher scientific Cat #: A-21206, RRID: AB_141708
Alexa Flour 555 Goat anti Mouse IgG2a (H+L) Thermo Fisher scientific Cat #: A-21137, RRID: AB_2535776
Alexa Flour 488 Donkey anti Goat IgG (H+L) Thermo Fisher scientific Cat #: A-11055, RRID: AB_142672
Anti-Mouse EpCAM APC (G8.8) eBioscience Cat #: 17-5791-80, RRID: AB_1659714
Anti-Mouse CD31 PE-Cyanine7 (390) eBioscience Cat #: 25-0311-81, RRID: AB_469615
PECy7 Rat anti-Mouse CD45 (30-F11) BD PharMingen Cat #: 561868, RRID: AB_10893599
PE/Cy5 anti-mouse Ly6A/E (Sca1) (D7) Biolegend Cat #: 108109, RRID: AB_313346
Biological Samples
Biopsies from human colon Herlev hospital O.H. Nielsen
Chemicals, Peptides, and Recombinant Proteins
Dextran Sulfate Sodium (DSS) MP Biomedicals 0216011090
Tamoxifen Sigma T5648
Growth factor reduced Matrigel Corning 356231
Cellmatrix Type I-A Nitta Gelatin 631-00651
human EGF Peprotech AF-100-15
murine Noggin Peprotech 250-38
human Noggin Peprotech 120-10C
mouse R-spondin1 R&D systems 3474-RS
human R-spondin1 Sino 11083-H08H
murine Wnt3a Cell guidance systems GFM77
Bovine Serum Albumin Sigma A9576
Nicotinamide Sigma 72340
Prostaglandin E2 Sigma P5640
Y-27632 dihydrochloride Sigma Y0503
Jagged-1 Anaspec AS-61298
CHIR99021 Stemgent 04-0004
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C3 toxin (Rho inhibitor I) Cytoskeleton CT04-A
Mevastatin Sigma M2537
Cytochalasin D Sigma C8273
FAK inhibitor (in vitro) Tocris PF573228
Src inhibitor (in vitro) Sigma Dasatinib
FAK inhibitor (in vivo) Selleckchem PND-1186
Src inhibitor (in vivo) Selleckchem Saracatinib
Verteporfin Sigma SML0534
Jagged-1 Anaspec AS-61298
Indomethacin Sigma I7378
Puromycin Sigma P8833
4-hydroxytamoxifen Sigma H6278
Critical Commercial Assays
Lipofectamin 2000 Thermo Fisher Scientific 11668027
Hematoxylin QS Vector H-3404
Eosin Y Solution Aqueous Sigma HT110232
Vector Red Alkaline Phosphatase (Red AP)
Substrate Kit
Vector SK-5100
Alexa Fluor 647 Phalloidin Molecular Probes A22287
PureLink RNA Micro-scale kit Invitrogen 12183016
Superscript III reverse transcriptase Invitrogen 18080093
Deposited Data
Raw and analyzed data from homeostatic and
repairing epithelium
This paper E-MTAB-5249
Raw and analyzed data from adult and fetal culture This paper E-MTAB-5246
Raw and analyzed data from Collagen and Matrigel
culture
This paper E-MTAB-5247
Experimental Models: Cell Lines
Wnt3a-expressing HEK293 cells H. Clevers n/a
Experimental Models: Organisms/Strains
Rosa26mT/mG A.G. Botton Muzumdar et al., 2007
tetO-YAP S127A F. Camargo Camargo et al., 2007
Yap1fl/fl D.J. Pan Zhang et al., 2010
Villin-CreERT2 S. Robine el Marjou et al., 2004
Tazfl/fl S. Piccolo Azzolin et al., 2014
RAG2/ Taconic C57BL/6NTac
Rosa26-rtTAM2 Jackson Laboratory Stock No: 006965
Oligonucleotides
sgRNA targeting exon 15 of Apc
(GCACTCAAAACGCTTTTGA)
B.K. Koo Schwank et al., 2013
Recombinant DNA
Cas9 Schwank et al., 2013 Addgene #41815
Software and Algorithms
NDP.view2 Hamamatsu U12388-01
ImageJ NIH image version 2.0.0-rc-41/1.50d
Adobe Photoshop CS6 Adobe version 13.0.6 x64
Gene set enrichment analysis http://software.broadinstitute.org/
gsea/index.jsp
n/a
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Costar 48 Well Clear TC-Treated Multiple Well Plates Corning 3548
Histoacryl Topical Skin Adhesive B.Braun/TissueSeal TS1050071FP
OCT compound CellPath KMA-0100-00A
Disposable microtome blades, S35 Feather 207500000CONTACT FOR REAGENTS AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Kim Jen-
sen (kim.jensen@bric.ku.dk)
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice
Unless otherwise specified, C57BL/6J mice (purchased from Taconic, Denmark) were used for the experiments. Transgenic murine
lines used in the experiments have been previously described: Rosa26mT/mG (Muzumdar et al., 2007), tetO-YAP S127A (kindly pro-
vided by F. Camargo (Camargo et al., 2007)), Yap1fl/fl (kindly provided by DJ Pan; (Zhang et al., 2010), Villin-CreERT2 (kindly provided
by S. Robine; el Marjou et al., 2004), Tazfl/f (Azzolin et al., 2014),RAG2/ (Taconic, US) andRosa26-rtTAM2 (stock #006965, Jackson
Laboratory).
Cohorts of C57BL/6J animals (3-6 months old) used for experimental colitis were female, immune compromised Rag2/ animals
(3-6 month old) used for transplantation experiments were a mix of males and females, and a mix of male and female Yapfl/fl;Tazfl/fl
(Villin-CreERT2 negative; controls) and Villin-CreERT2;Yapfl/fl;Tazfl/fl siblings (2 months old) on a C57Bl6 background were used for
assessing the role of YAP/TAZ in tissue repair. For in vitro cultures cells were obtained from animals ranging from embryonic day
16.5 to late adulthood (12 months).
None of the animals used in these studies had been subjected to prior procedures and were drug and test naive. All animals were
housed in SPF (specific pathogen free) animal facilities, in either open or individually ventilated cages always with companion mice,
and cages were placed under a 12hr light-dark cycle. Food and water were provided ad libitum. National animal ethics committees in
Denmark and Italy (OPBA of Padua and Italian Ministry of Health) reviewed and approved all animal experiments.
Experimental Colitis
Colitis was induced in C57/BL6J animals (3-6 months old) by administration of 2.5% DSS (MP Biomedicals; MW; 36.000-50.000) in
drinking water for 5 days followed by normal water. RAG2/ animals (3-6 months old) were subjected to 3.3% DSS. In Yapfl/fl;Tazfl/fl
(Villin-CreERT2 negative; controls) and Villin-CreERT2;Yapfl/fl;Tazfl/fl siblings (2 months old), deletion of YAP/TAZwas induced by intra-
peritoneal injections of Tamoxifen (3 mg/body; dissolved in corn oil; Sigma) 2 weeks before induction of experimental colitis. In this
case DSS (2.5%) was administered for 5 days. FAK inhibitor (PND-1186, Selleckchem, 150mg/kg) and Src inhibitor (Saracatinib,
AZD0530, Selleckchem, 50mg/kg) were administered via oral gavage from day 8 to day 12 after DSS initiation and analyzed at
day 12. Control animals were administered with solvent (0.5% w/v HPMC / 0.1% w/v Polysorbate 80 in water).
Transplantation
RAG2/ mice were infused twice with cultured intestinal epithelial cells on day 8 and day 11 after DSS initiation (Yui et al., 2012).
Donor cells from Rosa26mT/mG mice were cultured as described below in either Matrigel (Corning) or collagen type I gel (Cellmatrix
Type I-A; Nitta Gelatin). At passage 3, epithelial cells were released from matrix, and dissociated into sheets of epithelial cells. Cell
fragments from approximately 600 organoids were resuspended in 300mL of 5%Matrigel in PBS. A flexible catheter was inserted into
the colon of mice under general anesthesia (Isoflurane; Piramal Healthcare), and the cell suspension was subsequently infused
into the colonic lumen. The anus was sealed with surgical histoacryl glue (B. Brawn), which was removed after 3 hours. After trans-
plantation, animals were carefully monitored during recovery. From 1 day to 2 weeks after the second transplantation, recipient
mice were analyzed (see below). In competitive assay based on the deletion of YAP/TAZ, GFP positive organoids derived from
Villin-CreERT2;Yapfl/fl;Tazfl/fl and those fromRosa26mT/mGmicewere transplanted (500 organoids of each) after expansion inMatrigel.
After transplantation, mice received intraperitoneal injections of Tamoxifen (same as above) at day 12 and 13. Mice were analyzed
either at day 12, or at day 16.
Flow cytometry and colony forming assay
Colonic tissue was isolated in the repair phase at 12-16 days after DSS initiation, and the injured regions were isolated using a ste-
reomicroscope. Identical parts of colon from untreated animals were used as controls. Cells from the dissected tissue were isolatede3 Cell Stem Cell 22, 35–49.e1–e7, January 4, 2018
as reported (Yui et al., 2012). Briefly, each colonic fragment was finelyminced using razorblade, and subjected to enzymatic digestion
at 37C for 20 min with Collagenase type IX (Sigma, 0.45mg/mL) and Dispase I (Roche; 0.2U/mL) in 12.5mL DMEM in 50mL tube.
During incubation, the tube was shaken by hand every 2 min. After incubation, the solution was subjected to vigorous mechanical
dissociation. The total volume was adjusted to 40 mL with DMEM supplemented with 10% adult bovine serum (ABS) and cells
were pelleted by centrifugation at 500 g for 3 min. The resulting cell pellet was resuspended in 30% Percoll in Hank’s balanced
salt solution, transferred in a 15 mL-tube and spun at 800 g for 3 min. The resulting cell pellet was resuspended in 10 mL DMEM
and filtered through a 70mm-cell strainer (Falcon). To obtain a single cell suspension, cells were pelleted at 500 g for 3 min, resus-
pended in 5 mL TrypLE Express Enzyme (GIBCO) and incubated at 37C for 10 min. Cells were then pelleted, resuspended in
DMEM and stained for flow cytometry using EpCAM-APC, CD31-PECy7, CD45-PECy7, and Sca1-PECy5 for 30 min on ice. After
washing, 40,6-Diamidino-2-phenylindole dihydrochloride (DAPI; Sigma; 1mM) was added. Cells were subsequently sorted on a
FACSAria I (BD Bioscience) cell sorter. In in vitro organoids assay, each fraction (104 cells) were harvested in 25 mL dome shaped
Matrigel supplemented with Jagged-1 (Anaspec, 1 mM) and cultured in advanced DMEM/F12 (Thermo Fisher Scientific) supple-
mented with GlutaMAX (Thermo Fisher Scientific, 1%) and Penicillin/Streptomycin (Thermo Fisher Scientific, 0.5%) in the presence
of human EGF (Peprotech; 50ng/mL), murine Noggin (Peprotech; 100ng/mL), mouse R-spondin1 (R&D; 500ng/mL), murine Wnt3a
(Cell guidance systems; 100ng/ml), Chir99021 (Stemgent; 3 mM), Prostaglandin E2 (PGE2; Sigma; 2.5mM), Nicotinamide (Sigma;
10mM), N-2 supplement (Thermo Fisher Scientific; 1%) and B-27 supplement (Thermo Fisher Scientific; 2%). Y-27632 dihydrochlor-
ide (Sigma; 10mM) was used for first 3 days of culture, and medium was changed every 3 days. Organoids number formed in each
condition was manually identified at day 10.
Primary cultures of mouse small intestinal and colonic epithelial cells in Matrigel or collagen Type I
Small intestinal cryptswereharvested fromtheproximalpartof thesmall intestineusingEDTA (2mM,30min) inPBS.Coloniccryptswere
harvested using 10 mM EDTA and incubation time extended to 60 minutes. Harvested crypts were embedded in Matrigel or collagen
type I gel. AdvancedDMEM/F12withGlutaMAXandPenicillin/Streptomycinwas usedasbasalmediumand supplementedwith human
EGF,murine Noggin or humanNoggin (Peprotech; 100ng/mL), mouse R-spondin1 or human R-spondin1 (Sino; 500ng/mL). When indi-
cated,murineWnt3awas supplemented toENRmedium in combinationwith 1%BovineSerumAlbumin (BSA;Sigma) (ENRW). For effi-
cient expansion of colonic crypts,Nicotinamide (Sigma; 10mM)was supplemented.When indicated, Prostaglandin E2or Indomethacin
(Sigma, 10 mM) were supplemented in ENR or ENRWmedium, and collagen Type I gel was mixed with the same volume of Matrigel in
ENR or ENRWmedium. The growth under different conditions was quantified as seeding efficiency at day 6.
Apc KO organoids were generated using Cas9 (Addgene #41815) and sgRNA (GCACTCAAAACGCTTTTGA) targeting exon 15 of
Apc (plasmid backbone: Addgene #41819; plasmids were a kind gift fromDr. Bon-Kyoung Koo University of Cambridge, UK). Briefly,
WT organoids (derived in Matrigel) were dissociated into single cells using mechanical disruption and trypsin (Life Technologies) in-
cubation for 10-15min. Single cells were transfected with 0.7mg of Cas9-expressing plasmid and 0.7mg of the plasmid expressing the
gRNA targeting Apc, using Lipofectamin2000 (ThermoFisher). After addition of the transfection medium, the plate was centrifuged
at 600 g at 32C for 1 hour, followed by another 4-hour incubation at 37C.Cells were then collected, centrifuged and re-suspended in
Matrigel containing Jagged-1 and cultured in ENR medium supplemented with CHIR99021, Y-27632 and Nicotinamide. Two pas-
sages after transfection the medium was changed to EN (no R-spondin) for selection. Selected clones were verified by Sanger
sequencing. Parental wild-type and Apc KO organoids were both replated in collagen type I in EN or ENRW and growth under
each condition was quantified as seeding efficiency at day 5. Apc KO organoids were treated with Mevastatin (Sigma; 3 mM) and
Verteporfin (Sigma; 3 mM) in collagen Type I in ENmedium at day 2 after seeding, and the effects were quantified 3 days later. Control
cells were treated with Dimethyl Sulfoxide (DMSO; Sigma).
Small intestinal crypts were harvested fromRosa26rtTAM2/+; tetO-YAPS127A (rtTA/tetOYAP) mice (between 2 and 3months of age)
andwere cultured in collagen type I using ENR or ENRWconditions. To induce expression of the transgenic allele, doxycycline (doxy;
2mg/ml, Sigma) was added to the culturemedium (ENR) on the first day of culture. Additionally, Src inhibitor (Dasatinib; Sigma; 10 mM)
and FAK inhibitor (PF573228; Tocris; 10 mM) were supplemented in the medium (ENRW or ENR plus doxy) at day 2. The seeding
efficiency was measured after additional 3 days.
Analysis of chemical compounds affecting downstream components of integrin signaling was performed on crypts derived from
small intestine seeded in collagen type I gel/ENRW conditions. At day 2, C3 toxin (Cytoskelton), Mevastatin (Sigma), Cytochalasin D
(Sigma), FAK inhibitor and Src inhibitor were supplied to the culture medium at the concentrations indicated. Sphere numbers were
counted in each condition after 3 days of incubation. Control cells were cultured in the presence of DMSO.
Small intestinal crypts derived from Villin-CreERT2;Yapfl/fl;Tazfl/flmice were cultured in Matrigel/ENR condition. Fragments of orga-
noids were replated in collagen Type I under ENRW condition. At day 3, 4-hydroxytamoxifen (4OHT; Sigma; dissolved in ethanol;
1 mM) was supplemented to the culture medium and sphere numbers counted after 3 days to determine the effect of YAP/TAZ on
organoid growth. Control organoids were derived from Rosa26mT/mG mice. Organoids cultured in Matrigel/ENR condition were
labeled with GFP by lentiviral transduction using an empty pTRIPZ vector for transplantation assay. Organoids were dissociated
into cell fragments using TryPLE (37C, 5 minutes) and cell fragments were further dissociated into smaller fragments by
pipetting. Cell fragments was subsequently incubated for 4 hours at 37C with lentiviral particles in full medium containing EGF,
Noggin, R-spondin1, Chir99021, Nicotinamide, N-2, B-27 and Y-27632. After 4 hours, fragments were harvested into Matrigel
dome, and cultured in the same condition for 1 week. GFP positive clones were selected by Puromycin (Sigma; 2 mg/ml).Cell Stem Cell 22, 35–49.e1–e7, January 4, 2018 e4
For replating assay, small intestinal epithelial cells under collagen/ENRW plus Nicotinamide condition were sequentially passaged
intoMatrigel. For passaging, spheres were released from collagen type I gel by collagenase solution (0.63mg/mL collagenase Type XI
in PBS) and were mechanically dissociated into fragments by pipetting 10 times using P1000 pipettes. Y-27632 was supplemented
for the first 2 days after passaging. At Passage 3, cells were replated in Matrigel and cultured in ENRmedium. Control samples were
cultured in Matrigel/ENR medium.
In all experiments using organoids, cells were harvested from WT C57/BL6 animals (3-6 months old) unless otherwise stated. In
primary phase, approximately 300 crypts were seeded in a dome-shaped 25ml extracellular matrix droplet and 250ml culture medium
was added to each well in a 48-well plate (flat bottom; Corning). Medium was subsequently changed every 2-3 days. The day of har-
vest is defined as day 0. For the quantification of growth of organoids, seeding efficiency was manually identified as a percentage of
successful sphere formation in all seeded fragments.
Primary culture of human colonic epithelial cells in collagen Type I
Human colonic crypts were harvested from clinical biopsies as described for mouse colon and cultured with ENRW plus Nicotin-
amide/PGE2. The human cultures were established from intestinal pinch biopsies obtained from individuals scheduled for colonos-
copy at the Department of Gastroenterology, Herlev Hospital, where all examinations subsequently fell out normal. The biopsies are
obtained under strict anonymity. Accordingly, gender identity and age of the subjects cannot be recorded. The Scientific Ethics Com-
mittee of the Copenhagen Capital Region approved the use of this material for research purposes, and informed consent was ob-
tained from all patients.
Primary culture of fetal intestinal and colonic epithelial cells in Matrigel
Cultures were established from the proximal part of small intestine from E16.5 mouse fetuses. The intestine was opened longitudi-
nally and processed by mincing into small pieces. Epithelial compartment was dissociated by incubation in 2mM EDTA. Colonic tis-
sue was digested in collagenase solution (125mg/mL in PBS) for 45 min at 37C with vigorous pipetting by P1000 pipettes every
15 min. Isolated epithelial units were embedded in Matrigel and cultured in ENR. Wnt3a conditioned medium (50% in volume)
was additionally supplemented for colon.
METHODS DETAILS
Imaging and histology
Tissues and cells were fixed with 4% Paraformaldehyde (PFA) from 3 hours to overnight at 4C. Samples were embedded in OCT
compound (CellPath) and frozen. Eight mm-sections were prepared by cryotome (Leica CM3050S). Hematoxylin and Eosin (H&E)
staining (Hematoxylin QS; Vector, Eosin Y Solution Aqueous; Sigma) and Alkaline Phosphatase staining (Vector Red Alkaline Phos-
phatase Substrate kit; Vector) were performed following manufactures’ protocols. Images were acquired using NDP Zoomer Digital
Pathology slide scanner (Hamamatsu). Phalloidin (Alexa Flour 647 Phalloidin; Molecular Probes) staining was performed according to
manufacture’s protocol. Immunofluorescence analysis was done using antibodies listed in the Key Resources Table. DAPI was used
to counterstain nuclei. Fluorescence images were acquired using laser scanning confocal microscopes (Leica TSC SP8). Some im-
ages of engrafted patch were acquired using a Zeiss Imager.M2 microscope equipped with ORCA-R2 Digital CCD camera C10600
(Hamamatsu). Phase contrast images of organoids were acquired using a Leica DM IL LED Fluo microscope equipped with Leica
MC120 HD camera, or a Leica DM IRB inverted microscope equipped with a CCD camera (Leica DFC 450C). Macroscopic images
of colon were acquired using a Leica M165FC microscope equipped with Leica DFC310 FX camera. All images were subsequently
analyzed in NDP.view2 software, ImageJ, version 2.0.0-rc-41/1.50d and Adobe Photoshop CS6, version 13.0.6 x64.
Thickness of mucosa
The distance between crypt tip and muscularis mucosa was measured in H&E staining using NDP.view2 software. 4 animals each
from control and colitis at 2 weeks after DSS administration were analyzed. In each animal, the distance wasmeasured at 12 different
points in the distal region of the colon.
Quantification of denuded regions in colon
Harvested colon from Yapfl/fl;Tazfl/fl and Villin-CreERT2;Yapfl/fl;Tazfl/fl animals, or animals treated with FAK and Src inhibitors was
embedded as Swiss-rolls and processed to frozen sections. Denuded region was identified in H&E staining. The length of denuded
regions and the length of entire colon were measured using NDP.view2 software. The quantification of denuded regions was used to
reflect persisting tissue damage.
Quantification of immunofluorescence
All images within each series were acquired under the same setting of scanning confocal microscope, and were converted into gray
scale adapting the same pre-set. Intensity of b1 integrin/FAK/pSrc wasmeasured in ImageJ using line function tomeasuremean gray
value at the basolateral side of epithelium to perform 50 to 100 independent measurements. Max intensity of Phalloidin staining at
apical surface was measured using line function to determine max gray value at the apical side of the epithelium in 100 to 200 inde-
pendent measurements. Samples from 3 animals in homeostatis and 3 in the repair phase were analyzed in all quantification. Maxe5 Cell Stem Cell 22, 35–49.e1–e7, January 4, 2018
intensity of Phalloidin staining at apical surface of in vitro sample wasmeasured using plot profile function in ImageJ by drawing a line
penetrating the entire longitudinal aspect of cells. Samples from 6 Matrigel and 8 collagen specimens were analyzed. In each inde-
pendent specimen 10 to 40 independent measurements were performed depending on the size of samples. In all quantification,
mean background intensity was determined in each image, and this value was subtracted from the measured value, and this cor-
rected value was adapted as output.
Sequential sectioning of a grafted epithelial patch
After dissection of the colon from mouse, it was washed with PBS, opened longitudinally and imaged by stereomicroscopy. En-
grafted patches were dissected manually from the colon and fixed with 4% PFA for 3 hours. Tissue fragments were embedded in
OCT. This process preserve endogenous expression of tdTomato/GFP in sequential frozen sections obtained every 8mm.
Fibrillar collagen analysis
Fifteen mm frozen sections were prepared from mock-treated and DSS-treated colons. After washing with PBS for 5 min, sections
were placed in a drop of water in a glass-bottomMattek dishes. Sections were imaged using aHCXPLAPO lambda blue 20x, 0.70NA
IMM UV objective fitted on an inverted Leica SP5-X MP multiphoton Leica microscope connected to a Ti-Sapphire laser. Fibrillar
collagen was visualized by acquiring the second harmonic generation (SHG) signal between 410-450 nm after 2-photon excitation
at 860 nm. The SHG signal was collected in the backward direction using a hybrid detector (HyD SP). A regular bright field image of
the tissue was taken simultaneously with the SHG image by means of Supercontinuum White Light Laser excitation at 603 nm. All
images were captured with a resolution of 2048 3 2048 pixels, at 100 Hz.
RNA extraction and qRT-PCR
Total RNA was isolated using PureLink RNA Micro-scale kit (Invitrogen). cDNA was synthetized using Superscript III reverse tran-
scriptase (Invitrogen) and random primers. cDNA was synthetized from 300ng total RNA for all in vitro cultured cells or 2ml of total
RNA from sorted materials. qPCRwas performed with QuantStudio 6 Flex Real-Time PCR System (Life technologies) in SYBRGreen
analysis with optimized primer pairs. CT value was normalized to Tubb5, using the DCt method. Heatmaps from qPCR data were
generated from z-score transformed relative expression data.
Microarray
Illumina beadarrays
Expression analysis using Illumina bead arrays was performed as described previously (Wong et al., 2012). Briefly, RNA was quality
controlled for concentration, purity and integrity using spectroStar omega (BMG labtech) and Bioanalyzer (Agilent). The amplification
was performed using the TotalPrep 96-RNA Amplification kit (Ambion). Total RNA (300ng) was reverse transcribed into cDNA and
amplified by in vitro transcription to generate biotin-labeled cRNA. cRNA (1500ng) was hybridized to whole genome bead arrays
(MouseWG-6 v2.0 Expression BeadChip) according to the direct hybridization assay from Illumina and scanned using an Illumina
BeadArray scanner.
Affymetrix arrays
RNA quality was assessed using a Bioanalyzer for integrity and concentration. For cultured material RNA (200ng) were processed
and labeled for array hybridization using the Ambion WT Expression kit (Life Technologies). For sorted material, biotinylated
cDNA was synthesized from 1.8ng of total RNA using the Nugen Ovation Pico WTA System V2 kit. Five mg of ssDNA from sorted
material was subsequently fragmented and biotinylated (NuGen Encore Biotin Module). Labeled, fragmented cDNA (Affymetrix
GeneChipWT Terminal Labeling and Controls Kit) was hybridized to Mouse Gene 2.0 arrays for 16 hours at 45C (at 60 rpm) (Affy-
metrix GeneChip Hybridization, Wash, and Stain Kit). Arrays were washed and stained using the Affymetrix Fluidics Station 450,
and scanned using the Hewlett-Packard GeneArray Scanner 3000 7G.
Preprocessing of microarray data and calling of differentially expressed genes
Two different array platforms, Illumina Mouse WG6 v2.0 Expression BeadChip and Affymetrix Mouse Gene 2.0 ST Array platform,
were used in this work and they were processed separately.
*Illumina beadarrays
The Illumina BeadChip arrays were analyzed in R using the beadarray package (Dunning et al., 2007). Data were extracted directly
from the tiff images using the readIllumina function with the option ‘‘useImages=TRUE.’’ Gene annotations were obtained from the
illuminaMousev2.db package. Quality control was performed as suggested in the beadarray documentation, including the investiga-
tion of spatial effects. Data were normalized with the normalizeIllumina function using the neqc method, also from the beadarray
package. Differential expression was called in R using the limma package and following the procedures suggested in the documen-
tation (Ritchie et al., 2015).
*Affymetrix arrays
Affymetrix microarray data were analyzed in R using the oligo and affycoretools packages (Carvalho and Irizarry, 2010; MacDonald,
2008). Annotation was supplied by Affymetrix, which included both gene- and exon-level annotation. Only the gene-level information
was used in this work. Normalization and probe summarization was performed using the rma function in the oligo package with
default settings. Differential expression was called in R using the limma package (Ritchie et al., 2015).Cell Stem Cell 22, 35–49.e1–e7, January 4, 2018 e6
Gene set enrichment analysis (GSEA) and GO-analysis
Gene set enrichment analysis was performed using the Broad institute GSEA tool software.broadinstitute.org/gsea/index.jsp) with
standard settings. Based on samples numbers, gene_set permutation was used. Gene sets include a YAP signature gene set based
on genes that are upregulated > 2 fold betweenwt and YAP overexpressing intestinal epithelial cells (Gregorieff et al., 2015), intestinal
stem cell signature based on genes that are upregulated > 2 fold in Lgr5 expressing cells (Mun˜oz et al., 2012), a collagen type I signa-
ture gene set, which represent genes upregulated > 1.5 fold in collagen type when compared Matrigel cultures (n = 6, FDR < 0.1),
a fetal signature gene set representing genes that are upregulated > 2 fold in cultures of fetal versus adult intestinal
epithelial cells (n = 3, FDR < 0.05) and a repair signature representing genes that are upregulated > 2 fold in the repairing epithelium
(EpCAMposSca1highCD45negCD31neg) relative to the normal homeostatic epithelium (EpCAMposSca1negCD45negCD31neg) (n = 3,
FDR < 0.05). GO-term enrichment analysis for unbiased gene ontology analysis was performed using PANTHER Version 12.0
(http://pantherdb.org/).
QUANTIFICATION AND STATISTICAL ANALYSIS
The number of biological and technical replicates and the number of animals are indicated in figure legends and text. All tested an-
imals were included. Sample size was not predetermined. Experiments were performed without methods of randomization or blind-
ing. For all experiments with error bars, the standard error of the mean (SEM) was calculated to indicate the variation within each
experiment.
Specifically for Figure 1D: 4 animals per condition; Figures 1F–1H, 1K, 3A, S1E, S3A, and S3B: 3 animals per conditions; Figures
2B, 4D, 5B–5D, 5F, 5G, 6H, S4A, S4E, and S5A: 3 cultures obtained from independent animals per condition; Figure 3F: 5 animals per
condition; Figure 4B: 6 cultures obtained from independent animals per condition; Figures 5H and 5J: 6 control animals and 4 cDKO
animals; Figure 5M: 3 animals analyzed for the two phenotypes; Figure 6E: 3 and 4 animals analyzed at Day 12 and 16, respectively;
Figure S3G: 5, 5 and 3 for Control, FAK inhibitor and Src inhibitor experiments, respectively; Figure S4B: 6 and 8 individual structures
analyzed from Matrigel and collagen cultures, respectively. Significance was assessed using the indicated tests calculated in Prism
(GraphPad) or in R.
DATA AND SOFTWARE AVAILABILITY
Microarray data have been deposited at https://www.ebi.ac.uk/arrayexpress/ under the accession numbers as follows.
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